You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ACAD Exercise Disclosure
Brege Laura · SEC Form 4 · Filed Jun 1, 2026
Exercise
Reported value range
Not reported
Brege Laura Director
ACAD
Transaction date
May 29, 2026
Public filing date
Jun 1, 2026
Filing lag
Filed 3 days later
ACAD daily price context
Close on/before transaction
$21.66
May 29, 2026
First close after public filing
$20.89
Jun 2, 2026
30-day return after filing
+20.63%
Through Jul 1, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 8,107 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001365619-26-000002
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Acadia Pharmaceuticals Inc ACAD Current | Exercise | May 29, 2026 | Not reported |
| Acadia Pharmaceuticals Inc ACAD | Exercise | May 29, 2026 | $0 |
| Acadia Pharmaceuticals Inc ACAD | Award | May 29, 2026 | $0 |
| Acadia Pharmaceuticals Inc ACAD | Award | May 29, 2026 | $0 |